Quarterly history
AUM ($B)fundS&P 500(gap = α)/ Flow in/out
Behavior signals (lifetime)
Dip response
+1.83%
adds when stocks drop
when a holding falls −10%+
Middle response
-0.50%
baseline attrition
Rally response
-0.99%
trims into rallies
when a holding rises +10%+
Top positions · 13
| Ticker | $ value | % port | YoY | Hold time |
|---|---|---|---|---|
| BBIOBridgeBio Pharma, Inc. | $378M | 79.4% | +114.8% | 6.8 yr |
| SNDXSyndax Pharmaceuticals, | $31M | 6.5% | +90.1% | 6.3 yr |
| GLUEMonte Rosa Therapeutics, | $26M | 5.4% | +254.5% | 5.0 yr |
| BCAXBicara Therapeutics Inc. | $11M | 2.4% | +52.6% | 1.8 yr |
| BBOTBridgeBio Oncology Thera | $9M | 1.9% | — | 0.8 yr |
| CMPSCOMPASS Pathways plc | $8M | 1.7% | +93.4% | 2.8 yr |
| SRRKScholar Rock Holding Cor | $4M | 0.8% | +52.9% | 0.8 yr |
| BMEABiomea Fusion, Inc. | $3M | 0.7% | -28.2% | 5.0 yr |
| — | $2M | 0.5% | — | 0.3 yr |
| URGNUroGen Pharma Ltd. | $2M | 0.4% | +62.6% | 0.5 yr |
| ACRSAclaris Therapeutics, In | $2M | 0.3% | +145.1% | 7.3 yr |
| — | $0M | 0.1% | — | 3.0 yr |
| OKUROnKure Therapeutics, Inc | $0M | 0.1% | -3.7% | 1.5 yr |
Portfolio composition (YoY)
Industry mix
Biotechnology97.8%-0.9pp$466M
Medical - Care Facilities1.7%+0.5pp$8M
Unknown0.6%+0.4pp$3M
Country
US97.8%+12.6pp
GB1.7%-13.1pp
Unknown0.6%+0.4pp
Top 5: 95.5% · Top 10: 99.5% · Top 25: 100.0%
Top buys this quarter · 4
| BBOT BridgeBio Oncology Therapeutic | +$4M |
| GLUE Monte Rosa Therapeutics, Inc. | +$1M |
| CMPS COMPASS Pathways plc | +$8M |
| — new | +$0M |
Top sells this quarter · 1
| CALC CalciMedica, Inc.exit | −$0M |
Quarterly history (TTM returns)
| Period | AUM | # Pos | Return (1yr) | SPY (1yr) | Alpha (1yr) | Flow |
|---|---|---|---|---|---|---|
| 2026-03-31 | $476M | 13 | +114.47% | +17.59% | +96.88% | +0.01B |
| 2025-12-31 | $479M | 13 | +149.38% | +17.72% | +131.67% | -0.19B |
| 2025-09-30 | $456M | 14 | +68.78% | +17.52% | +51.26% | +0.00B |
| 2025-06-30 | $360M | 13 | +38.09% | +14.94% | +23.15% | +0.02B |
| 2025-03-31 | $288M | 13 | -8.76% | +8.30% | -17.07% | -0.03B |
| 2024-12-31 | $282M | 15 | -32.50% | +24.89% | -57.39% | +0.02B |
| 2024-09-30 | $261M | 16 | -0.95% | +36.04% | -36.99% | +0.02B |
| 2024-06-30 | $231M | 15 | +17.00% | +24.49% | -7.49% | -0.00B |
| 2024-03-31 | $295M | 16 | +46.07% | +29.62% | +16.45% | +0.01B |
| 2023-12-31 | $335M | 16 | +164.63% | +26.18% | +138.45% | -0.02B |
| 2023-09-30 | $243M | 17 | +56.66% | +21.57% | +35.10% | -0.01B |
| 2023-06-30 | $204M | 16 | +34.67% | +19.42% | +15.25% | +0.00B |
| 2023-03-31 | $208M | 16 | +18.22% | -7.82% | +26.03% | -0.02B |
| 2022-12-31 | $151M | 16 | -14.06% | +7.56% | -21.62% | +0.02B |
| 2022-09-30 | $151M | 17 | +4.74% | -4.93% | +9.67% | +0.00B |
| 2022-06-30 | $140M | 19 | -13.98% | -16.11% | +2.14% | -0.02B |